Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity

J Hepatol. 2017 Jun;66(6):1130-1137. doi: 10.1016/j.jhep.2017.01.032. Epub 2017 Feb 10.

Abstract

Background & aims: The Fc receptor family for immunoglobulin (Ig)G type III (FcγRIII, CD16) is an activating receptor on natural killer (NK) cells and an essential mediator of antibody-dependent cellular cytotoxicity (ADCC). There is only limited information on its role during chronic hepatitis C virus (HCV) infection. We studied CD16 expression in relation to NK cell functional activity in HCV-infected patients and sought mechanistic insights into virus-induced modulation.

Methods: NK cell CD16 expression and activation status were evaluated ex vivo by flow cytometry in HCV-infected patients and healthy controls (HC) as well as in vitro after co-culture with HCV-infected HuH7.5 cells. Rituximab-mediated ADCC was assessed in HC and HCV-infected patients using Daudi cells as a target. The role of metzincins in CD16 down-modulation was assessed using specific inhibitory molecules and by evaluating intracellular mRNA levels.

Results: HCV-infected patients exhibited increased frequencies of ex vivo activated NK cells and a concomitantly decreased NK CD16 expression, which resulted in impaired ADCC activity. Moreover, exposure of NK cells to culture-derived HCV recapitulated the ex vivo findings of decreased CD16 expression and increased NK cell activation. Importantly, blockade of metzincin-mediated shedding activity, including selective a disintegrin and metalloproteinase 17 (ADAM-17) inhibition, restored NK CD16 expression. Successful treatment with direct-acting antivirals partially improved NK ADCC function despite delayed CD16 reconstitution.

Conclusion: Chronic HCV infection induces NK cell activation resulting in ADAM-17-dependent CD16 shedding and consequent impaired ADCC function. Altered ADCC may contribute to failure to eradicate HCV-infected hepatocytes.

Lay summary: We show here that hepatitis C virus (HCV) activates natural killer (NK) lymphocytes which, as a consequence, loose their Fc receptor for IgG (CD16), an essential molecule for antibody binding. We show that this occurs through the action of enzymes named metzincins, resulting in altered NK-mediated antibody-dependent killing (ADCC) of target cells. This mechanism may contribute to HCV persistence and may represent a general phenomenon whereby some viruses can escape host's immune responses.

Keywords: ADAM-17; Anti-viral agents; Antibody-dependent cell cytotoxicity; CD69; DAAs; Disintegrins; FcγRIII; HCV; MMP9; Natural killer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibody-Dependent Cell Cytotoxicity*
  • Antiviral Agents / therapeutic use
  • Cell Line
  • Coculture Techniques
  • GPI-Linked Proteins / metabolism
  • Hepacivirus / immunology*
  • Hepatitis C, Chronic / enzymology*
  • Hepatitis C, Chronic / immunology*
  • Hepatitis C, Chronic / virology
  • Humans
  • Killer Cells, Natural / enzymology
  • Killer Cells, Natural / immunology*
  • Killer Cells, Natural / virology*
  • Lymphocyte Activation
  • Metalloproteases / metabolism*
  • Receptors, IgG / metabolism*
  • Sustained Virologic Response

Substances

  • Antiviral Agents
  • FCGR3B protein, human
  • GPI-Linked Proteins
  • Receptors, IgG
  • Metalloproteases